| mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.0037 |
0.9 |